Investigating the effects of ABC transporter-based acquired drug resistance mechanisms at the cellular and tissue scale

Integrative Biology (United Kingdom)

Volumn 5, Issue 3, 2013, Pages 555-568

  Liu, Cong ^a   Krishnan, J ^a   Xu, Xiao Yun ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER;

APOPTOSIS; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; DRUG TRANSPORT; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84874804687     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20238g     Document Type: Article

References (29)

1. A. Di Paolo G. Bocci Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification Curr. Oncol. Rep. 2007 9 109 114
2. O. Trédan C. M. Galmarini K. Patel I. F. Tannock Drug resistance and the solid tumor microenvironment J. Natl. Cancer Inst. 2007 99 1441 1454
3. A. I. Minchinton I. F. Tannock Drug penetration in solid tumours Nat. Rev. Cancer 2006 6 583 592
4. R. O'Connor M. Clynes P. Dowling N. O'Donovan L. O'Driscoll Drug resistance in cancer-searching for mechanisms, markers and therapeutic agents Expert Opin. Drug Metab. Toxicol. 2007 3 805 817
5. M. M. Gottesman Mechanisms of cancer drug resistance Annu. Rev. Med. 2002 53 615 627
6. H. R. Mellor R. Callaghan Resistance to chemotherapy in cancer: a complex and integrated cellular response Pharmacology 2008 81 275 300
7. A.-M. Florea D. Büsselberg Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects Cancers 2011 3 1351 1371
8. A. Morel A. Basseville L. Preisser S. D. Trecesson M. Boisdron-Celle E. Gamelin O. Coqueret Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells Mol. Cancer 2011 10
9. C. Liu J. Krishnan X. Y. Xu A systems-based mathematical modelling framework for investigating the effect of drugs on solid tumours Theor. Biol. Med. Modell. 2011 8 45
10. R. Maitra P. A. Halpin K. H. Karlson R. L. Page D. Y. Paik M. O. Leavitt B. D. Moyer B. A. Stanton J. W. Hamilton Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression Biochem. J. 2001 355 617 624
11. M. Demeule M. Brossard R. Beliveau Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter Am. J. Physiol. 1999 277 F832 F840
12. K. T. Luu J. A. Uchizono P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model Pharm. Res. 2005 22 710 715
13. A. Ballesta J. Clairambault S. Dulong F. Levi Theoretical optimization of Irinotecan-based anticancer strategies in the case of drug-induced efflux Appl. Math. Lett. 2011 24 1251 1256
14. G. A. Truskey, F. Yuan and D. F. Katz, Transport phenomena in biological systems, Pearson Prentice Hall, 2009
15. T. Eissing H. Conzelmann E. D. Gilles F. Allgower E. Bullinger P. Scheurich Bistability analyses of a caspase activation model for receptor-induced apoptosis J. Biol. Chem. 2004 279 36892 36897
16. S. Legewie N. Bluthgen H. Herzel Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability PLoS Comput. Biol. 2006 2 1061 1073
17. C. Gu J. Zhang Y. Chen J. Lei A trigger model of apoptosis induced by tumor necrosis factor signaling BMC Syst. Biol. 2011 5 Suppl 1 S13
18. J. G. Albeck J. M. Burke S. L. Spencer D. A. Lauffenburger P. K. Sorger Modeling a snap-action, variable-delay switch controlling extrinsic cell death PLoS Biol. 2008 6 2831 2852
19. J. Krishnan and C. Liu, Systems and Synthetic Biology: A Systematic View, ed., V. Kulkarni, G.-B. Stan, and, K. Raman, Springer-Verlag, 2012
20. J. W. Thomas, Numerical partial differential equations, Springer, 1995
21. K. J. Patel I. F. Tannock The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors BMC Cancer 2009 9
22. J. K. Tunggal T. Melo J. R. Ballinger I. F. Tannock The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers Int. J. Cancer 2000 86 101 107
23. S. Eikenberry A tumor cord model for doxorubicin delivery and dose optimization in solid tumors Theor. Biol. Med. Modell. 2009 6 16
24. G. M. Thurber R. Weissleder A Systems Approach for Tumor Pharmacokinetics PLoS One 2011 6 e24696
25. R. K. Jain Transport of molecules in the tumor interstitium: a review Cancer Res. 1987 47 3039 3051
26. B. Fallica G. Makin M. H. Zaman Bioengineering approaches to study multidrug resistance in tumor cells Integr. Biol. 2011 3 529 539
27. C. Liu J. Krishnan J. Stebbing X. Y. Xu Use of mathematical models to understand anticancer drug delivery and its effect on solid tumors Pharmacogenomics 2011 12 1337 1348
28. A. W. El-Kareh T. W. Secomb A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells Neoplasia 2000 2 325 338
29. D. Seaton J. Krishnan A modular systems approach to elucidating the interaction of adaptive and monostable and bistable threshold modules IET Syst. Biol. 2011 5 81 94